Full
Outline
To study the therapeutic mechanism of resolving blood stasis and regulating tendons acupuncture combined with Zhuyu Zhitong Decoction（逐瘀止痛汤）in the treatment of lumbar disc herniation.
Eighty-six patients diagnosed with lumbar disc herniation were selected and divided into two groups according to random number table. Forty-three cases in the reference group were treated with resolving blood stasis and regulating tendons acupuncture，and the other forty three cases in the study group were treated with resolving blood stasis and regulating tendons acupuncture and Zhuyu Zhitong Decoction. The clinical efficacy，TCM syndrome scores，inflammatory factor levels and lumbar function of the two groups were observed and compared.
The total effective rate of the study group was 95.35%，higher than that（74.42%）of the control group. The difference was statistically significant（P<0.05）. After treatment，the lumbar function in the study group was higher than that in the reference group，and the difference was statistically significant（P<0.05）. After treatment，the levels of interleukin-6（IL-6），interleukin-17（IL-17）and tumor necrosis factor-α（TNF-α）in the study group were lower than those in the reference group，and the difference was statistically significant（P<0.05）. After treatment，compared with those of the reference group，VAS score and muscle strength were higher and ODIscore was lower in the study group，and the differences were statistically significant（P<0.05）. After treatment，compared with those of the reference group，the pelvic lateral inclination，pelvic tilt angle and sagittal plane flat axis of the study group were smaller，and the lumbar lordosis angle was larger. The differences were statistically significant（P<0.05）.
The patients with lumbar disc herniation were treated by resolving blood stasis and regulating tendons acupuncture and Zhuyu Zhitong Decoction，which can effectively improve the function of the lumbar spine，reduce the inflammatory response of the body and promote the recovery of the patients，and have high clinical application value.
46
19
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |
关闭全屏
No. 86 Xueyuan South Road, Haidian District, Beijing
010-62662699(Operation and Technical Support)
qkjq@cast.org.cn
Copyright © 2025 China Association for Science and Technology. All rights reserved. For all open access content, the relevant licensing terms apply.
Sponsored by the Office of the Leading Group for Cybersecurity and Informatization of CAST, and supported by Science and Technology Review Publishing House
